Ipamorelin is a synthetic pentapeptide and selective growth hormone secretagogue receptor ligand, supplied as a lyophilised powder in a sealed single-use vial for laboratory and analytical research purposes only. Stock is held and dispatched from Australia with tracking, typically within 1-2 business days of order.
Specifications - Compound: Ipamorelin. Sequence: Aib-His-D-2-Nal-D-Phe-Lys-NH2. Format: lyophilised powder. Quantity: 5mg per vial. Purity: 98% minimum, analytically verified. Appearance: white lyophilised powder. Molecular weight: approximately 711.9 g/mol. CAS number: 170851-70-4. Storage: 2-8 degrees C, sealed, protected from light. Intended use: laboratory research only.
Research context - Ipamorelin is a short synthetic pentapeptide studied for its selectivity at the growth hormone secretagogue receptor. Laboratory interest centres on receptor binding specificity, comparative studies against earlier secretagogue peptides such as GHRP-2 and GHRP-6, and its behaviour in in-vitro receptor assays. Because of its compact sequence and reported selectivity profile, it is frequently used as a reference ligand in receptor-binding research. Genesis Peptides supplies Ipamorelin in lyophilised form to preserve compound integrity during transport and storage.
Handling and storage - Store the sealed vial refrigerated at 2-8 degrees C and protect it from heat and light. Reconstitute using bacteriostatic water and follow established laboratory handling protocols. Reconstituted material has a materially shorter stable life than lyophilised powder and should be kept refrigerated.
Compliance notice - This product is supplied strictly for laboratory research use only. Not for human consumption, veterinary use, or therapeutic application. Not listed with the TGA. Genesis Peptides does not provide medical, therapeutic, or clinical guidance.